MedTrace Logo

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

NCT02416414 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2016-03-29

No results posted yet for this study

Summary

To compare the performance of the QuantiFERON Monitor assay against existing methodology.

Conditions

  • Cell-mediated Immune Response

Interventions

DEVICE

QuantiFERON Monitor Assay

Assay to measure cell-mediated immune function using QuantiFERON Monitor assay.

DEVICE

Existing methodology

Assay to measure cell-mediated immune function using existing methodology.

Sponsors & Collaborators

  • QIAGEN Gaithersburg, Inc

    lead INDUSTRY

Principal Investigators

  • Camille N Kotton, M.D. · Transplant and Immunocompromised Host Infectious Diseases

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02416414 on ClinicalTrials.gov